{"gene":"HIF1A","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":2007,"finding":"HIF-1α is hydroxylated at proline residues 402 and/or 564 by PHD2 (prolyl hydroxylase domain protein 2), promoting binding of the von Hippel-Lindau protein (VHL), leading to ubiquitination and proteasomal degradation. HIF-1α is also hydroxylated at asparagine residue 803 by FIH-1 (factor inhibiting HIF-1), blocking binding of the p300/CBP coactivator. Both hydroxylation reactions utilize O2 and alpha-ketoglutarate as substrates.","method":"Biochemical pathway dissection; enzymatic assays; mutagenesis studies synthesized in pathway review","journal":"Science's STKE","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple independent labs, reconstituted enzymatic reactions, mutagenesis; widely replicated foundational mechanism","pmids":["17925579"],"is_preprint":false},{"year":2007,"finding":"RACK1 competes with HSP90 for binding to the PAS-A domain of HIF-1α and promotes O2/PHD/VHL-independent, proteasome-dependent degradation of HIF-1α by binding Elongin-C and recruiting the Elongin-B/C E3 ubiquitin ligase complex to HIF-1α.","method":"Co-immunoprecipitation, domain-mapping pulldown, ubiquitination assay, proteasome inhibitor experiments","journal":"Cell cycle (Georgetown, Tex.)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, domain mapping, functional ubiquitination assay in single focused study with multiple orthogonal methods","pmids":["17361105"],"is_preprint":false},{"year":2001,"finding":"Jab1 (Jun activation domain-binding protein 1, fifth subunit of COP9 signalosome) directly interacts with HIF-1α, increases HIF-1α protein stability, enhances HIF-1 transcriptional activity under hypoxia (increasing VEGF expression), and interferes with the binding of p53 to HIF-1α in a Jab1-dependent manner.","method":"Yeast two-hybrid screening, GST pull-down assay, co-immunoprecipitation in HEK 293 cells, reporter assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, GST pulldown, functional reporter assay; single lab, multiple orthogonal methods","pmids":["11707426"],"is_preprint":false},{"year":2005,"finding":"HIF-1α represses expression of MSH2 and MSH6 (the MutSα mismatch repair complex) by displacing the transcriptional activator Myc from Sp1 binding sites at MutSα gene promoters; Sp1 serves as a molecular switch recruiting HIF-1α to the promoter under hypoxia. This is p53-dependent and causes nucleotide-level genetic instability.","method":"Reporter assays, ChIP, siRNA knockdown, gel-shift assays, genetic analysis of human colon cancer specimens","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, reporter assay, functional epistasis (p53-dependence), multiple orthogonal methods, replicated in cell lines and patient specimens","pmids":["15780936"],"is_preprint":false},{"year":2019,"finding":"HIF-1α transcriptionally upregulates p53 (both WT and MT) by binding to five response elements in the p53 promoter under hypoxia. The resulting hypoxia-induced p53 protein (transcriptionally inactive) acts as a chaperone, binding HIF-1α and stabilizing its association with downstream DNA response elements (HREs), thereby increasing HIF-1α-regulated gene synthesis.","method":"ChIP, luciferase reporter assay, co-immunoprecipitation, protein-DNA binding assays, siRNA knockdown","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, reporter assay, Co-IP, multiple orthogonal methods; single lab","pmids":["31538203"],"is_preprint":false},{"year":2009,"finding":"TNFα induces HIF-1α protein accumulation (without affecting HIF-1α mRNA) in an IKKβ-dependent manner. IKKβ overexpression increases HIF-1α protein, and IKKβ inhibition or knockout reduces TNFα-induced HIF-1α and VEGF expression.","method":"Western blot, stable transfection, siRNA knockdown, pharmacological inhibition (Bay 11-7082), MEF IKKβ knockout cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO + pharmacological inhibition + overexpression, single lab with multiple orthogonal methods","pmids":["19766100"],"is_preprint":false},{"year":2017,"finding":"The histone demethylase KDM4A controls HIF-1α levels by removing the repressive H3K9me3 mark at the HIF1A locus; KDM4A depletion or inactivation causes H3K9me3 accumulation at the HIF1A locus, decreasing HIF-1α mRNA and protein, and reduces hypoxia-driven invasion, migration, and oxygen consumption.","method":"KDM4A siRNA knockdown, ChIP for H3K9me3 at HIF1A locus, RT-qPCR, invasion/migration assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, KD with defined phenotype, mRNA/protein readouts; single lab","pmids":["28894274"],"is_preprint":false},{"year":2022,"finding":"Intermittent hypoxia (minutes) increases HIF-1α protein through a distinct pathway from chronic hypoxia: KDM4A, KDM4B, and KDM4C histone demethylases are activated by intermittent hypoxia, removing H3K9me3 at the HIF1A locus and increasing HIF1A mRNA. Chronic hypoxia conversely decreases KDM4A/B/C activity, leading to H3K9me3 hypertrimethylation at the HIF1A locus.","method":"H3K9me3 ChIP at HIF1A locus, RT-qPCR, KDM4A/B/C inhibition and depletion, protein activity assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with locus-specific readout, multiple KDM knockdowns, single lab with multiple methods","pmids":["36174675"],"is_preprint":false},{"year":2024,"finding":"PADI4 directly interacts with HIF-1α and citrullinates it at arginine R698. This citrullination blocks VHL binding to HIF-1α, thereby antagonizing HIF-1α ubiquitination and proteasomal degradation, stabilizing HIF-1α.","method":"Co-immunoprecipitation, in vitro citrullination assay, site-directed mutagenesis (R698), VHL binding assay, ubiquitination assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic reconstitution with mutagenesis, Co-IP, ubiquitination assay; single lab but multiple orthogonal Tier 1 methods","pmids":["39227578"],"is_preprint":false},{"year":2023,"finding":"USP51 forms a complex with VHL E3 ligase components (USP51/VHL/CUL2/ELOB/ELOC/RBX1) and directly deubiquitinates HIF-1α, stabilizing it and activating hypoxia-induced gene transcription. Conversely, HIF-1α transcriptionally upregulates USP51, forming a positive feedback loop. SUMOylation of ELOC at K32 inhibits USP51 binding; SENP1-mediated deSUMOylation of ELOC promotes USP51-ELOC interaction and HIF-1α deubiquitination.","method":"Co-immunoprecipitation, in vitro deubiquitination assay, ChIP, reporter assay, site-directed mutagenesis (ELOC K32), SUMO assay","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro deubiquitination reconstitution, Co-IP of complex, mutagenesis, ChIP; single lab with multiple Tier 1–2 methods","pmids":["37816999"],"is_preprint":false},{"year":2023,"finding":"BAP1 (BRCA1-associated protein 1) binds HIF-1α during hypoxia, deubiquitylates it, and stabilizes it. BAP1 interacts with the N-terminal region of HIF-1α (where HIF-1α binds DNA and dimerizes with HIF-1β). Mutations of BAP1 residues I675, F678, I679, and L691 abolish interaction with HIF-1α. Loss of BAP1 reduces nuclear HIF-1α levels in hypoxia.","method":"Co-immunoprecipitation, computational modeling, BAP1 siRNA knockdown, mutagenesis of BAP1 interaction domain, patient mesothelioma biopsy IHC","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — Co-IP with domain mutagenesis, functional deubiquitylation, siRNA KD in primary cells, single lab with multiple orthogonal methods","pmids":["36656861"],"is_preprint":false},{"year":2017,"finding":"PER2 (period circadian clock 2) interacts with HIF-1α and functions as an effector molecule facilitating recruitment of HIF-1α to hypoxia response elements (HREs), including the VEGF promoter HRE. PER2-mediated HIF-1 activation requires HIF-1α N803 to be unhydroxylated (by hypoxia, N803A mutation, or FIH inhibitor deferoxamine), though PER2-HIF-1α interaction itself is independent of N803 hydroxylation status.","method":"Co-immunoprecipitation, ChIP, luciferase HRE reporter assay, point mutation (N803A), pharmacological FIH inhibition (deferoxamine), PER2 overexpression","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, ChIP, reporter assay, mutagenesis; single lab with multiple orthogonal methods","pmids":["28963769"],"is_preprint":false},{"year":2019,"finding":"HIF1A and NFAT5 coordinate high-salt (Na+)-boosted antibacterial defense in macrophages: HIF1A-dependent increased autophagy and NFAT5-dependent targeting of intracellular E. coli to acidic autolysosomal compartments are both required. The antibacterial activity was not dependent on NOS2 or phagocyte oxidase.","method":"Conditional KO (LysM-Cre Hif1a and NFAT5 deletion), bacterial colony forming unit assays, autophagic flux assays, lysosomal acidification assays","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type specific genetic KO with defined antibacterial phenotype, multiple readouts; single lab","pmids":["30982460"],"is_preprint":false},{"year":2021,"finding":"HIF-1α activates non-canonical target genes in oligodendrocyte progenitor cells (OPCs) through physical interaction with the OPC-specific transcription factor OLIG2; non-canonical targets Ascl2 and Dlx3 suppress Sox10 and block oligodendrocyte differentiation. MEK/ERK inhibition restores Sox10 expression and oligodendrocyte generation without affecting canonical HIF-1α activity.","method":"Chronic HIF-1α accumulation model in PSC-derived OPCs, ChIP-seq, gene expression profiling, chemical MEK/ERK inhibitor screen, human oligocortical spheroid model","journal":"Cell stem cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-seq, genetic loss-of-function with defined phenotype, chemical rescue; single lab with multiple orthogonal methods","pmids":["33091368"],"is_preprint":false},{"year":2021,"finding":"Cardiac fibroblast-specific deletion of Hif-1a leads to increased mitochondrial ROS after myocardial infarction, resulting in ~50% increased cardiac fibroblast proliferation and excessive scarring. The mitochondrial-targeted antioxidant MitoTEMPO rescues the mutant phenotype, indicating HIF-1α acts as a brake against excessive post-ischemic fibroblast activation through regulation of mitochondrial ROS.","method":"CF-specific Cre-lox Hif-1a deletion, scRNA-seq, 3D engineered cardiac microtissues, MitoParaquat treatment, MitoTEMPO rescue, ROS measurement","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific genetic KO, scRNA-seq, rescue with targeted antioxidant, 3D tissue model; multiple orthogonal methods with mechanistic rescue","pmids":["34762860"],"is_preprint":false},{"year":2012,"finding":"HIF-1α directly binds to functional hypoxia response elements (HREs) in the S100A8 and S100A9 promoters (confirmed by ChIP) and activates their transcription in prostate cancer cells, as demonstrated by promoter luciferase reporter constructs.","method":"ChIP, luciferase promoter reporter assay, HIF-1α overexpression, siRNA knockdown, hypoxia treatment","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP + reporter assay + KD/OE; single lab with multiple orthogonal methods","pmids":["22505354"],"is_preprint":false},{"year":2012,"finding":"HIF1A binds to HRE elements in the WASF3 (WAVE3) gene promoter under hypoxic conditions (confirmed by ChIP), activating WASF3 transcription and promoting cell motility and invasion; WASF3 knockdown abolishes the hypoxic invasion response.","method":"ChIP, luciferase reporter assay, WASF3 siRNA knockdown, scratch wound motility assay, hypoxia treatment","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, reporter assay, functional KD; single lab with multiple methods","pmids":["22581642"],"is_preprint":false},{"year":2009,"finding":"Intracellular calcium elevation (via ionomycin) and calmodulin activity are required for hypoxia-induced HIF-1 transcriptional activation, acting upstream of the ERK pathway. ERK pathway inhibition (PD98059) blocks HIF-1 activation by both hypoxia and ionomycin without affecting HIF-1α protein level or DNA binding, indicating calcium/calmodulin→ERK regulates HIF-1 transcriptional activity post-DNA binding.","method":"Pharmacological inhibition (ionomycin, BAPTA, calmodulin dominant-negative mutant, PD98059, KN-93), HIF-1 reporter assay, electrophoretic mobility shift assay (EMSA)","journal":"Annals of the New York Academy of Sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pharmacological inhibitors only, single lab, no genetic validation","pmids":["12485909"],"is_preprint":false},{"year":2019,"finding":"STAT1 functions as a transcriptional suppressor of HIF1A: ATG7 deletion in endothelial cells upregulates STAT1 (via an autophagy-independent mechanism involving ZNF148/ZFP148 nuclear translocation), which binds the HIF1A promoter and suppresses HIF1A expression, impairing angiogenesis. HIF1A overexpression rescues the ATG7-deficiency angiogenesis defect.","method":"EC-specific Atg7 KO mouse, ChIP (STAT1 on HIF1A promoter), HIF1A overexpression rescue, ZNF148 nuclear fractionation, fludarabine STAT1 inhibition","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, genetic KO with defined phenotype, rescue experiment; single lab","pmids":["36300763"],"is_preprint":false},{"year":2024,"finding":"CARM1 is physically associated with and directly interacts with HIF1A; CARM1 is recruited by HIF1A and occupies promoters of CDK4, Cyclin D1, β-Catenin, HIF1A, MALAT1, and SIX1, modulating proliferation and invasion in triple-negative breast cancer.","method":"Co-immunoprecipitation, ChIP-seq (genome-wide CARM1 occupancy), siRNA knockdown, overexpression functional assays","journal":"Protein & cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP-seq with functional KD; single lab","pmids":["38476024"],"is_preprint":false},{"year":2009,"finding":"HIF-1α loss from skeletal muscle (conditional KO) increases oxidative capacity and constitutively activates AMP-activated protein kinase (AMPK), decreases expression of pyruvate dehydrogenase kinase I (a HIF-1α target), and increases capillary-to-fiber ratio, demonstrating HIF-1α normally suppresses mitochondrial biogenesis and oxidative metabolism in skeletal muscle.","method":"Skeletal muscle-specific Hif-1α KO mice, respiratory exchange ratio, capillary density quantification, oxidative enzyme activity, AMPK activation assay","journal":"Advances in experimental medicine and biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — tissue-specific genetic KO with multiple defined phenotypic readouts; single lab","pmids":["18269201"],"is_preprint":false},{"year":2020,"finding":"In bovine granulosa cells, HIF1 transcriptionally regulates steroidogenesis genes (STAR, HSD3B, CYP19A1) and proliferation genes (CCND2, PCNA); CYP19A1 (aromatase) is a direct downstream target of HIF1, as demonstrated by ChIP showing HIF1A binding to its promoter.","method":"Echinomycin inhibition, siRNA knockdown, ChIP, radioimmunoassay (estradiol), RT-qPCR","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP + functional KD with gene expression and hormone assay; single lab","pmids":["32127571"],"is_preprint":false},{"year":2009,"finding":"HIF-1 activates transcription of pyruvate dehydrogenase kinase 1 (PDK1), which shunts pyruvate away from mitochondria, and BNIP3, which triggers selective mitochondrial autophagy, thereby coordinating a shift from oxidative phosphorylation to glycolysis under hypoxia.","method":"Transcriptional target gene analysis, reporter assays, genetic deletion models (synthesized in review of primary experiments)","journal":"Current opinion in genetics & development","confidence":"Medium","confidence_rationale":"Tier 2 / Strong — PDK1 and BNIP3 as HIF-1 transcriptional targets established by multiple independent labs with reporter and ChIP data","pmids":["19942427"],"is_preprint":false}],"current_model":"HIF-1α is an oxygen-sensitive bHLH-PAS transcription factor that, under hypoxia, escapes PHD2-mediated prolyl hydroxylation (at P402/P564) and VHL-dependent ubiquitin-proteasomal degradation, dimerizes with HIF-1β, recruits coactivators p300/CBP (whose binding is also regulated by FIH-1-mediated N803 hydroxylation), and drives transcription of hundreds of target genes including VEGF, glycolytic enzymes, PDK1, and BNIP3; its stability is additionally controlled by O2-independent mechanisms including RACK1-mediated (competing with HSP90) and BAP1/USP51 deubiquitylase-mediated pathways, post-translational modifications such as PADI4-mediated citrullination at R698 that blocks VHL binding, epigenetic regulation of the HIF1A locus via KDM4A/H3K9me3, and interactions with partners including Jab1, PER2, CARM1, and p53 that modulate its transcriptional output in a context-dependent manner."},"narrative":{"mechanistic_narrative":"HIF-1α is the master oxygen-sensitive bHLH-PAS transcription factor that reprograms cellular physiology in response to hypoxia [PMID:17925579, PMID:19942427]. Under normoxia its stability and activity are controlled by O2-dependent dioxygenases: PHD2 hydroxylates P402/P564 to license VHL-mediated ubiquitination and proteasomal degradation, while FIH-1 hydroxylates N803 to block recruitment of the p300/CBP coactivator, both using O2 and α-ketoglutarate as cosubstrates [PMID:17925579]. Beyond this canonical axis, HIF-1α abundance is set by O2-independent inputs that converge on the same ubiquitin machinery: RACK1 competes with HSP90 for the PAS-A domain and recruits the Elongin-B/C ligase to drive degradation [PMID:17361105], whereas the deubiquitylases USP51 (acting within a VHL/CUL2/ELOB/ELOC complex regulated by SENP1-dependent deSUMOylation of ELOC) and BAP1 remove ubiquitin to stabilize HIF-1α [PMID:37816999, PMID:36656861]; PADI4-mediated citrullination at R698 stabilizes the protein by blocking VHL binding [PMID:39227578], and inflammatory signaling through IKKβ raises HIF-1α protein without changing its mRNA [PMID:19766100]. HIF1A expression is additionally gated epigenetically, with KDM4-family histone demethylases removing repressive H3K9me3 at the locus—an axis that distinguishes intermittent from chronic hypoxia—and STAT1 acting as a transcriptional repressor of the promoter [PMID:28894274, PMID:36174675, PMID:36300763]. Once stabilized and dimerized, HIF-1α binds hypoxia response elements to activate a metabolic and angiogenic program, inducing PDK1 and BNIP3 to shift cells from oxidative phosphorylation to glycolysis [PMID:19942427] and driving targets including VEGF, S100A8/A9, WASF3, and CYP19A1 [PMID:11707426, PMID:22505354, PMID:22581642, PMID:32127571]. Its transcriptional output is shaped combinatorially by partner factors—PER2 facilitates HRE recruitment, p53 acts as a chaperone stabilizing HIF-1α at HREs, CARM1 co-occupies target promoters, Sp1 switches HIF-1α onto the MutSα mismatch-repair genes to repress them, and OLIG2 redirects HIF-1α to non-canonical targets in oligodendrocyte progenitors [PMID:28963769, PMID:31538203, PMID:38476024, PMID:15780936, PMID:33091368]. Physiologically, HIF-1α enforces tissue-specific outcomes, suppressing mitochondrial biogenesis in skeletal muscle [PMID:18269201], limiting post-ischemic cardiac fibroblast proliferation by controlling mitochondrial ROS [PMID:34762860], and supporting macrophage autophagy-dependent antibacterial defense [PMID:30982460].","teleology":[{"year":2001,"claim":"Identifying Jab1 as a direct HIF-1α partner showed that protein-protein interactions, not just oxygen chemistry, govern HIF-1α stability and activity.","evidence":"Yeast two-hybrid, GST pulldown, Co-IP and reporter assays in HEK293 cells","pmids":["11707426"],"confidence":"Medium","gaps":["Structural basis of the Jab1-HIF-1α interface not defined","Whether Jab1 acts via the COP9 signalosome in this context untested"]},{"year":2005,"claim":"Demonstrating that HIF-1α displaces Myc at Sp1 sites to repress MutSα genes established HIF-1α as a context-dependent transcriptional repressor causing genetic instability, not only an activator.","evidence":"ChIP, reporter and gel-shift assays, siRNA, p53-dependence epistasis in colon cancer cells and patient specimens","pmids":["15780936"],"confidence":"High","gaps":["Generality of the Sp1 switch to other promoters unknown","Direct vs indirect role of p53 in repression not fully resolved"]},{"year":2007,"claim":"Dissection of PHD2/VHL and FIH-1 hydroxylation reactions defined the dual O2-dependent control of HIF-1α stability and coactivator recruitment, the foundational oxygen-sensing mechanism.","evidence":"Enzymatic assays and mutagenesis synthesized in pathway review","pmids":["17925579"],"confidence":"High","gaps":["Quantitative O2 thresholds for each hydroxylase in vivo not specified","Crosstalk between the two hydroxylation events under graded hypoxia"]},{"year":2007,"claim":"Showing RACK1 competes with HSP90 and recruits Elongin-B/C established an O2/PHD/VHL-independent route to HIF-1α degradation, expanding stability control beyond the hydroxylase axis.","evidence":"Reciprocal Co-IP, domain mapping, ubiquitination and proteasome-inhibitor assays","pmids":["17361105"],"confidence":"High","gaps":["Physiological signals that tip the HSP90/RACK1 balance unclear","Tissue contexts where this pathway dominates not defined"]},{"year":2009,"claim":"Linking TNFα/IKKβ to HIF-1α protein accumulation connected inflammatory signaling to HIF-1α independent of transcription, broadening its regulatory inputs.","evidence":"Western blot, overexpression, siRNA, pharmacological inhibition and IKKβ-KO MEFs","pmids":["19766100"],"confidence":"Medium","gaps":["Molecular step by which IKKβ raises HIF-1α protein not identified","Whether degradation or translation is targeted unresolved"]},{"year":2009,"claim":"Tissue-specific knockouts revealed HIF-1α as a physiological brake on oxidative metabolism in skeletal muscle and a coordinator of the glycolytic switch via PDK1 and BNIP3.","evidence":"Skeletal-muscle Hif1a KO mice with metabolic phenotyping; transcriptional target analysis of PDK1/BNIP3","pmids":["18269201","19942427"],"confidence":"Medium","gaps":["Relative contribution of individual targets to the metabolic phenotype unclear","Cross-tissue generality of the metabolic brake untested"]},{"year":2012,"claim":"ChIP-validated direct targets S100A8/A9 and WASF3 connected HIF-1α transcriptional activity to invasion and motility programs in cancer cells.","evidence":"ChIP, reporter assays, siRNA knockdown, motility assays under hypoxia","pmids":["22505354","22581642"],"confidence":"Medium","gaps":["Contribution relative to other invasion targets not quantified","In vivo metastasis dependence not established"]},{"year":2017,"claim":"Defining KDM4A-mediated H3K9me3 removal at the HIF1A locus established epigenetic control of HIF1A transcription as a distinct regulatory layer.","evidence":"KDM4A siRNA, H3K9me3 ChIP at HIF1A, RT-qPCR, invasion/migration assays","pmids":["28894274"],"confidence":"Medium","gaps":["Upstream signals controlling KDM4A activity at this locus unknown","Single-lab observation"]},{"year":2017,"claim":"Identifying PER2 as an effector that recruits HIF-1α to HREs tied circadian machinery to hypoxic transcription and linked it mechanistically to N803 hydroxylation status.","evidence":"Reciprocal Co-IP, ChIP, HRE reporter, N803A mutation and FIH inhibition","pmids":["28963769"],"confidence":"Medium","gaps":["Whether PER2 acts on canonical or specific subsets of HREs unclear","Circadian timing of the effect not directly tested"]},{"year":2019,"claim":"p53 was shown to act both as a HIF-1α transcriptional target and as a chaperone stabilizing HIF-1α at HREs, revealing reciprocal HIF-1α/p53 regulation.","evidence":"ChIP, luciferase reporter, Co-IP, protein-DNA binding, siRNA","pmids":["31538203"],"confidence":"Medium","gaps":["Mechanism by which transcriptionally inactive p53 stabilizes DNA binding unclear","In vivo relevance of the feed-forward loop untested"]},{"year":2019,"claim":"Genetic dissection placed HIF1A within macrophage salt-boosted antibacterial defense and identified STAT1 as a transcriptional repressor of HIF1A controlling angiogenesis.","evidence":"Conditional/EC-specific KO mice, ChIP, autophagy/lysosomal assays, HIF1A overexpression rescue","pmids":["30982460","36300763"],"confidence":"Medium","gaps":["Direct HIF-1α target genes in the antibacterial program not all defined","STAT1 repression generality across tissues unknown"]},{"year":2021,"claim":"Cell-type-specific studies established HIF-1α as a protective brake on cardiac fibroblast proliferation via mitochondrial ROS control and as a driver of non-canonical, OLIG2-dependent transcription blocking oligodendrocyte differentiation.","evidence":"Conditional Hif1a KO, scRNA-seq, ChIP-seq, MitoTEMPO rescue, MEK/ERK inhibitor rescue, spheroid models","pmids":["34762860","33091368"],"confidence":"High","gaps":["How HIF-1α selects non-canonical vs canonical targets mechanistically unresolved","ROS target genes mediating the fibroblast brake not enumerated"]},{"year":2023,"claim":"Discovery of USP51 and BAP1 as HIF-1α deubiquitylases established active deubiquitylation, including a SENP1/SUMO-regulated USP51 feedback loop, as a positive arm of HIF-1α stability control.","evidence":"Co-IP of complexes, in vitro deubiquitination, ChIP, ELOC K32 and BAP1 interaction-domain mutagenesis, patient IHC","pmids":["37816999","36656861"],"confidence":"High","gaps":["Relative contribution of USP51 vs BAP1 across cell types unclear","Conditions activating each DUB physiologically not defined"]},{"year":2024,"claim":"Identification of PADI4-mediated R698 citrullination as a VHL-blocking modification, and CARM1 as a recruited co-regulator on shared promoters, extended the post-translational and cofactor repertoire controlling HIF-1α.","evidence":"In vitro citrullination, Co-IP, R698 mutagenesis, VHL/ubiquitination assays; CARM1 Co-IP and ChIP-seq with functional knockdown","pmids":["39227578","38476024"],"confidence":"High","gaps":["Signals controlling PADI4 recruitment to HIF-1α unknown","Whether CARM1 methylates HIF-1α directly not established"]},{"year":null,"claim":"How the many parallel stability inputs (hydroxylation, RACK1, DUBs, citrullination, IKKβ) and combinatorial cofactors are integrated to set context-specific HIF-1α target selection remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified quantitative model linking competing stability pathways","Determinants of canonical vs non-canonical target choice undefined","Structural basis of most HIF-1α cofactor interfaces unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3,4,15,16,21,22]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[4,15,16]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[10]}],"pathway":[{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[0,22]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,15,16,22]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[20,22]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,8,9,10]}],"complexes":[],"partners":["VHL","PHD2","FIH1","RACK1","PADI4","USP51","BAP1","PER2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q16665","full_name":"Hypoxia-inducible factor 1-alpha","aliases":["ARNT-interacting protein","Basic-helix-loop-helix-PAS protein MOP1","Class E basic helix-loop-helix protein 78","bHLHe78","Member of PAS protein 1","PAS domain-containing protein 8"],"length_aa":826,"mass_kda":92.7,"function":"Functions as a master transcriptional regulator of the adaptive response to hypoxia (PubMed:11292861, PubMed:11566883, PubMed:15465032, PubMed:16973622, PubMed:17610843, PubMed:18658046, PubMed:20624928, PubMed:22009797, PubMed:30125331, PubMed:9887100). Under hypoxic conditions, activates the transcription of over 40 genes, including erythropoietin, glucose transporters, glycolytic enzymes, vascular endothelial growth factor, HILPDA, and other genes whose protein products increase oxygen delivery or facilitate metabolic adaptation to hypoxia (PubMed:11292861, PubMed:11566883, PubMed:15465032, PubMed:16973622, PubMed:17610843, PubMed:20624928, PubMed:22009797, PubMed:30125331, PubMed:9887100). Plays an essential role in embryonic vascularization, tumor angiogenesis and pathophysiology of ischemic disease (PubMed:22009797). Heterodimerizes with ARNT; heterodimer binds to core DNA sequence 5'-TACGTG-3' within the hypoxia response element (HRE) of target gene promoters (By similarity). Activation requires recruitment of transcriptional coactivators such as CREBBP and EP300 (PubMed:16543236, PubMed:9887100). Activity is enhanced by interaction with NCOA1 and/or NCOA2 (PubMed:10594042). Interaction with redox regulatory protein APEX1 seems to activate CTAD and potentiates activation by NCOA1 and CREBBP (PubMed:10202154, PubMed:10594042). Involved in the axonal distribution and transport of mitochondria in neurons during hypoxia (PubMed:19528298) (Microbial infection) Upon infection by human coronavirus SARS-CoV-2, is required for induction of glycolysis in monocytes and the consequent pro-inflammatory state (PubMed:32697943). In monocytes, induces expression of ACE2 and cytokines such as IL1B, TNF, IL6, and interferons (PubMed:32697943). Promotes human coronavirus SARS-CoV-2 replication and monocyte inflammatory response (PubMed:32697943)","subcellular_location":"Cytoplasm; Nucleus; Nucleus speckle","url":"https://www.uniprot.org/uniprotkb/Q16665/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HIF1A","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/HIF1A","total_profiled":1310},"omim":[{"mim_id":"621537","title":"CPS1 INTRONIC TRANSCRIPT 1, NONCODING; CPS1IT1","url":"https://www.omim.org/entry/621537"},{"mim_id":"621518","title":"SYNAPTOTAGMIN 17; SYT17","url":"https://www.omim.org/entry/621518"},{"mim_id":"621517","title":"HYPOXIA-INDUCIBLE NONCODING ENHANCER RNA 1","url":"https://www.omim.org/entry/621517"},{"mim_id":"621019","title":"PRE-mRNA-PROCESSING FACTOR 40 HOMOLOG B; PRPF40B","url":"https://www.omim.org/entry/621019"},{"mim_id":"621007","title":"ZINC FINGER PROTEIN 800; ZNF800","url":"https://www.omim.org/entry/621007"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"},{"location":"Nuclear bodies","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":423.5}],"url":"https://www.proteinatlas.org/search/HIF1A"},"hgnc":{"alias_symbol":["MOP1","HIF-1alpha","PASD8","HIF1","bHLHe78"],"prev_symbol":[]},"alphafold":{"accession":"Q16665","domains":[{"cath_id":"3.30.450.20","chopping":"79-150_163-204_215-225","consensus_level":"high","plddt":90.1602,"start":79,"end":225},{"cath_id":"3.30.450.20","chopping":"240-360","consensus_level":"high","plddt":93.804,"start":240,"end":360}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16665","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16665-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16665-F1-predicted_aligned_error_v6.png","plddt_mean":60.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HIF1A","jax_strain_url":"https://www.jax.org/strain/search?query=HIF1A"},"sequence":{"accession":"Q16665","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16665.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16665/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16665"}},"corpus_meta":[{"pmid":"13130303","id":"PMC_13130303","title":"Targeting HIF-1 for cancer therapy.","date":"2003","source":"Nature reviews. Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/13130303","citation_count":5451,"is_preprint":false},{"pmid":"10749844","id":"PMC_10749844","title":"HIF-1: mediator of physiological and pathophysiological responses to hypoxia.","date":"2000","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/10749844","citation_count":1438,"is_preprint":false},{"pmid":"16887934","id":"PMC_16887934","title":"Hypoxia-inducible factor-1 (HIF-1).","date":"2006","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16887934","citation_count":1320,"is_preprint":false},{"pmid":"19942427","id":"PMC_19942427","title":"HIF-1: upstream and downstream of cancer metabolism.","date":"2009","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/19942427","citation_count":1082,"is_preprint":false},{"pmid":"23999440","id":"PMC_23999440","title":"HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations.","date":"2013","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23999440","citation_count":1073,"is_preprint":false},{"pmid":"11248550","id":"PMC_11248550","title":"HIF-1 and mechanisms of hypoxia sensing.","date":"2001","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11248550","citation_count":1022,"is_preprint":false},{"pmid":"11927290","id":"PMC_11927290","title":"HIF-1 and tumor progression: pathophysiology and therapeutics.","date":"2002","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11927290","citation_count":829,"is_preprint":false},{"pmid":"17925579","id":"PMC_17925579","title":"Hypoxia-inducible factor 1 (HIF-1) pathway.","date":"2007","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/17925579","citation_count":733,"is_preprint":false},{"pmid":"25784597","id":"PMC_25784597","title":"HIF-1 at the crossroads of hypoxia, inflammation, and cancer.","date":"2015","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25784597","citation_count":457,"is_preprint":false},{"pmid":"15780936","id":"PMC_15780936","title":"HIF-1alpha induces genetic instability by transcriptionally downregulating MutSalpha expression.","date":"2005","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15780936","citation_count":289,"is_preprint":false},{"pmid":"18809331","id":"PMC_18809331","title":"HIF-1 regulation: not so easy come, easy go.","date":"2008","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/18809331","citation_count":279,"is_preprint":false},{"pmid":"30411685","id":"PMC_30411685","title":"Role of HIF-1 in Cancer Progression: Novel Insights. A Review.","date":"2018","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30411685","citation_count":252,"is_preprint":false},{"pmid":"17404612","id":"PMC_17404612","title":"HIF-1 and HIF-2: working alone or together in hypoxia?","date":"2007","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17404612","citation_count":232,"is_preprint":false},{"pmid":"11191064","id":"PMC_11191064","title":"HIF-1: using two hands to flip the angiogenic switch.","date":"2000","source":"Cancer metastasis reviews","url":"https://pubmed.ncbi.nlm.nih.gov/11191064","citation_count":208,"is_preprint":false},{"pmid":"15144945","id":"PMC_15144945","title":"Intratumoral hypoxia, radiation resistance, and HIF-1.","date":"2004","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/15144945","citation_count":199,"is_preprint":false},{"pmid":"14726713","id":"PMC_14726713","title":"HIF-1: an oxygen and metal responsive transcription factor.","date":"2004","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/14726713","citation_count":191,"is_preprint":false},{"pmid":"19929412","id":"PMC_19929412","title":"Relationships between cycling hypoxia, HIF-1, angiogenesis and oxidative stress.","date":"2009","source":"Radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/19929412","citation_count":189,"is_preprint":false},{"pmid":"34762860","id":"PMC_34762860","title":"Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction.","date":"2021","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/34762860","citation_count":185,"is_preprint":false},{"pmid":"20016290","id":"PMC_20016290","title":"HIF-1alpha dysfunction in diabetes.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/20016290","citation_count":167,"is_preprint":false},{"pmid":"11707426","id":"PMC_11707426","title":"Jab1 interacts directly with HIF-1alpha and regulates its stability.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11707426","citation_count":161,"is_preprint":false},{"pmid":"11698256","id":"PMC_11698256","title":"HIF-1 expression in healing wounds: HIF-1alpha induction in primary inflammatory cells by TNF-alpha.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11698256","citation_count":160,"is_preprint":false},{"pmid":"15601571","id":"PMC_15601571","title":"HIF-1 and p53: communication of transcription factors under hypoxia.","date":"2004","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15601571","citation_count":150,"is_preprint":false},{"pmid":"18815367","id":"PMC_18815367","title":"Distinct size distribution of endogeneous siRNAs in maize: Evidence from deep sequencing in the mop1-1 mutant.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18815367","citation_count":149,"is_preprint":false},{"pmid":"20392254","id":"PMC_20392254","title":"Role of HIF-1alpha in skeletal development.","date":"2010","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/20392254","citation_count":148,"is_preprint":false},{"pmid":"17361105","id":"PMC_17361105","title":"RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/17361105","citation_count":140,"is_preprint":false},{"pmid":"15108809","id":"PMC_15108809","title":"HIF-1 and hypoxic response: the plot thickens.","date":"2004","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/15108809","citation_count":128,"is_preprint":false},{"pmid":"15313402","id":"PMC_15313402","title":"New anticancer strategies targeting HIF-1.","date":"2004","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15313402","citation_count":128,"is_preprint":false},{"pmid":"19264039","id":"PMC_19264039","title":"HIF-1: a key mediator in hypoxia.","date":"2009","source":"Acta physiologica Hungarica","url":"https://pubmed.ncbi.nlm.nih.gov/19264039","citation_count":125,"is_preprint":false},{"pmid":"15313390","id":"PMC_15313390","title":"HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs.","date":"2004","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15313390","citation_count":119,"is_preprint":false},{"pmid":"13678535","id":"PMC_13678535","title":"HIF-1 in cell cycle regulation, apoptosis, and tumor progression.","date":"2003","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/13678535","citation_count":101,"is_preprint":false},{"pmid":"28318896","id":"PMC_28318896","title":"Role of AHR and HIF-1α in Glioblastoma Metabolism.","date":"2017","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/28318896","citation_count":100,"is_preprint":false},{"pmid":"24735366","id":"PMC_24735366","title":"HIF-1 signaling in drug resistance to chemotherapy.","date":"2014","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24735366","citation_count":96,"is_preprint":false},{"pmid":"36028854","id":"PMC_36028854","title":"ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription.","date":"2022","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/36028854","citation_count":94,"is_preprint":false},{"pmid":"17878221","id":"PMC_17878221","title":"HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes.","date":"2007","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17878221","citation_count":91,"is_preprint":false},{"pmid":"27456341","id":"PMC_27456341","title":"Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.","date":"2016","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/27456341","citation_count":85,"is_preprint":false},{"pmid":"16144691","id":"PMC_16144691","title":"Hypoxia and HIF-1 alpha in chondrogenesis.","date":"2005","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16144691","citation_count":84,"is_preprint":false},{"pmid":"8557036","id":"PMC_8557036","title":"Schizosaccharomyces pombe Mop1-Mcs2 is related to mammalian CAK.","date":"1995","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8557036","citation_count":78,"is_preprint":false},{"pmid":"27903434","id":"PMC_27903434","title":"Hypoxia and HIF-1 activation in bacterial infections.","date":"2016","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/27903434","citation_count":76,"is_preprint":false},{"pmid":"33401572","id":"PMC_33401572","title":"Flavonoids Targeting HIF-1: Implications on Cancer Metabolism.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33401572","citation_count":75,"is_preprint":false},{"pmid":"30808328","id":"PMC_30808328","title":"HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia.","date":"2019","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30808328","citation_count":73,"is_preprint":false},{"pmid":"24676782","id":"PMC_24676782","title":"Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.","date":"2014","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24676782","citation_count":73,"is_preprint":false},{"pmid":"28963769","id":"PMC_28963769","title":"A circadian clock gene, PER2, activates HIF-1 as an effector molecule for recruitment of HIF-1α to promoter regions of its downstream genes.","date":"2017","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/28963769","citation_count":70,"is_preprint":false},{"pmid":"23160373","id":"PMC_23160373","title":"The growing complexity of HIF-1α's role in tumorigenesis: DNA repair and beyond.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23160373","citation_count":67,"is_preprint":false},{"pmid":"28701304","id":"PMC_28701304","title":"HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28701304","citation_count":65,"is_preprint":false},{"pmid":"22505354","id":"PMC_22505354","title":"Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.","date":"2012","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22505354","citation_count":62,"is_preprint":false},{"pmid":"31538203","id":"PMC_31538203","title":"HIF-transcribed p53 chaperones HIF-1α.","date":"2019","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/31538203","citation_count":59,"is_preprint":false},{"pmid":"20033376","id":"PMC_20033376","title":"HIF-1alpha and cancer therapy.","date":"2010","source":"Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20033376","citation_count":59,"is_preprint":false},{"pmid":"36351894","id":"PMC_36351894","title":"PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36351894","citation_count":58,"is_preprint":false},{"pmid":"35023280","id":"PMC_35023280","title":"Ferroptosis-related gene NOX4, CHAC1 and HIF1A are valid biomarkers for stomach adenocarcinoma.","date":"2022","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35023280","citation_count":57,"is_preprint":false},{"pmid":"18800226","id":"PMC_18800226","title":"Feminized tassels of maize mop1 and ts1 mutants exhibit altered levels of miR156 and specific SBP-box genes.","date":"2008","source":"Planta","url":"https://pubmed.ncbi.nlm.nih.gov/18800226","citation_count":57,"is_preprint":false},{"pmid":"20032376","id":"PMC_20032376","title":"Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.","date":"2009","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/20032376","citation_count":54,"is_preprint":false},{"pmid":"18708172","id":"PMC_18708172","title":"HIF-1 and ventilatory acclimatization to chronic hypoxia.","date":"2008","source":"Respiratory physiology & neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/18708172","citation_count":53,"is_preprint":false},{"pmid":"30216500","id":"PMC_30216500","title":"The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30216500","citation_count":51,"is_preprint":false},{"pmid":"30982460","id":"PMC_30982460","title":"HIF1A and NFAT5 coordinate Na+-boosted antibacterial defense via enhanced autophagy and autolysosomal targeting.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/30982460","citation_count":50,"is_preprint":false},{"pmid":"20958262","id":"PMC_20958262","title":"HIF-1 as a target for cancer chemotherapy, chemosensitization and chemoprevention.","date":"2011","source":"Current molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20958262","citation_count":50,"is_preprint":false},{"pmid":"16219782","id":"PMC_16219782","title":"The mop1 (mediator of paramutation1) mutant progressively reactivates one of the two genes encoded by the MuDR transposon in maize.","date":"2005","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16219782","citation_count":49,"is_preprint":false},{"pmid":"32127571","id":"PMC_32127571","title":"HIF1 driven transcriptional activity regulates steroidogenesis and proliferation of bovine granulosa cells.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32127571","citation_count":48,"is_preprint":false},{"pmid":"35848884","id":"PMC_35848884","title":"HNRNPC downregulation inhibits IL-6/STAT3-mediated HCC metastasis by decreasing HIF1A expression.","date":"2022","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/35848884","citation_count":48,"is_preprint":false},{"pmid":"12485909","id":"PMC_12485909","title":"ERK and calcium in activation of HIF-1.","date":"2002","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/12485909","citation_count":47,"is_preprint":false},{"pmid":"18269201","id":"PMC_18269201","title":"The role of HIF-1 in hypoxic response in the skeletal muscle.","date":"2007","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/18269201","citation_count":46,"is_preprint":false},{"pmid":"33091368","id":"PMC_33091368","title":"Non-canonical Targets of HIF1a Impair Oligodendrocyte Progenitor Cell Function.","date":"2020","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/33091368","citation_count":46,"is_preprint":false},{"pmid":"34878158","id":"PMC_34878158","title":"HIF‑1α in cerebral ischemia (Review).","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/34878158","citation_count":45,"is_preprint":false},{"pmid":"35386720","id":"PMC_35386720","title":"Cholesterol and HIF-1α: Dangerous Liaisons in Atherosclerosis.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35386720","citation_count":45,"is_preprint":false},{"pmid":"28894274","id":"PMC_28894274","title":"KDM4A regulates HIF-1 levels through H3K9me3.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28894274","citation_count":45,"is_preprint":false},{"pmid":"31282018","id":"PMC_31282018","title":"Modeling the regulation of p53 activation by HIF-1 upon hypoxia.","date":"2019","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/31282018","citation_count":45,"is_preprint":false},{"pmid":"16831906","id":"PMC_16831906","title":"Hypoxia and HIF-1alpha in chondrogenesis.","date":"2006","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/16831906","citation_count":44,"is_preprint":false},{"pmid":"23712868","id":"PMC_23712868","title":"AGR2 expression is regulated by HIF-1 and contributes to growth and angiogenesis of glioblastoma.","date":"2013","source":"Cell biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/23712868","citation_count":42,"is_preprint":false},{"pmid":"28642579","id":"PMC_28642579","title":"Regulation of glycolysis in brown adipocytes by HIF-1α.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28642579","citation_count":42,"is_preprint":false},{"pmid":"37816999","id":"PMC_37816999","title":"USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A.","date":"2023","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/37816999","citation_count":41,"is_preprint":false},{"pmid":"32679233","id":"PMC_32679233","title":"HIF-1a regulates hypoxia-induced autophagy via translocation of ANKRD37 in colon cancer.","date":"2020","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32679233","citation_count":41,"is_preprint":false},{"pmid":"31966690","id":"PMC_31966690","title":"Circulating exosomes and exosomal lncRNA HIF1A-AS1 in atherosclerosis.","date":"2017","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31966690","citation_count":39,"is_preprint":false},{"pmid":"35948068","id":"PMC_35948068","title":"HIF1, HSF1, and NRF2: Oxidant-Responsive Trio Raising Cellular Defenses and Engaging Immune System.","date":"2022","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/35948068","citation_count":38,"is_preprint":false},{"pmid":"28165644","id":"PMC_28165644","title":"HIF1A gene polymorphisms and human diseases: Graphical review of 97 association studies.","date":"2017","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28165644","citation_count":36,"is_preprint":false},{"pmid":"27031712","id":"PMC_27031712","title":"HIF-1--a big chapter in the cancer tale.","date":"2016","source":"Experimental oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27031712","citation_count":36,"is_preprint":false},{"pmid":"30665327","id":"PMC_30665327","title":"EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC.","date":"2019","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/30665327","citation_count":35,"is_preprint":false},{"pmid":"31671642","id":"PMC_31671642","title":"Improved Motor Nerve Regeneration by SIRT1/Hif1a-Mediated Autophagy.","date":"2019","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31671642","citation_count":35,"is_preprint":false},{"pmid":"30332653","id":"PMC_30332653","title":"The p38α Stress Kinase Suppresses Aneuploidy Tolerance by Inhibiting Hif-1α.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30332653","citation_count":34,"is_preprint":false},{"pmid":"30651591","id":"PMC_30651591","title":"Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.","date":"2019","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30651591","citation_count":33,"is_preprint":false},{"pmid":"32450824","id":"PMC_32450824","title":"Independence of HIF1a and androgen signaling pathways in prostate cancer.","date":"2020","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32450824","citation_count":33,"is_preprint":false},{"pmid":"37178248","id":"PMC_37178248","title":"HIF-1 signaling: an emerging mechanism for mitochondrial dynamics.","date":"2023","source":"Journal of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37178248","citation_count":31,"is_preprint":false},{"pmid":"31043706","id":"PMC_31043706","title":"Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31043706","citation_count":31,"is_preprint":false},{"pmid":"22581642","id":"PMC_22581642","title":"HIF1A induces expression of the WASF3 metastasis-associated gene under hypoxic conditions.","date":"2012","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22581642","citation_count":31,"is_preprint":false},{"pmid":"29753320","id":"PMC_29753320","title":"Adverse effects of Hif1a mutation and maternal diabetes on the offspring heart.","date":"2018","source":"Cardiovascular diabetology","url":"https://pubmed.ncbi.nlm.nih.gov/29753320","citation_count":29,"is_preprint":false},{"pmid":"36300763","id":"PMC_36300763","title":"Ablation of endothelial Atg7 inhibits ischemia-induced angiogenesis by upregulating Stat1 that suppresses Hif1a expression.","date":"2022","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/36300763","citation_count":28,"is_preprint":false},{"pmid":"39981236","id":"PMC_39981236","title":"Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/39981236","citation_count":28,"is_preprint":false},{"pmid":"39227578","id":"PMC_39227578","title":"Citrullination modulation stabilizes HIF-1α to promote tumour progression.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/39227578","citation_count":26,"is_preprint":false},{"pmid":"28366537","id":"PMC_28366537","title":"HIF has Biff - Crosstalk between HIF1a and the family of bHLH/PAS proteins.","date":"2017","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28366537","citation_count":26,"is_preprint":false},{"pmid":"29758199","id":"PMC_29758199","title":"PAFAH1B2 is a HIF1a target gene and promotes metastasis in pancreatic cancer.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/29758199","citation_count":26,"is_preprint":false},{"pmid":"36174675","id":"PMC_36174675","title":"Intermittent hypoxia enhances the expression of hypoxia inducible factor HIF1A through histone demethylation.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36174675","citation_count":26,"is_preprint":false},{"pmid":"36656861","id":"PMC_36656861","title":"BAP1 is a novel regulator of HIF-1α.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36656861","citation_count":25,"is_preprint":false},{"pmid":"19766100","id":"PMC_19766100","title":"TNFalpha induces HIF-1alpha expression through activation of IKKbeta.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19766100","citation_count":25,"is_preprint":false},{"pmid":"37733588","id":"PMC_37733588","title":"FSHR-mTOR-HIF1 signaling alleviates mouse follicles from AMPK-induced atresia.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37733588","citation_count":24,"is_preprint":false},{"pmid":"16888453","id":"PMC_16888453","title":"Leukocyte's Hif-1 expression and training-induced erythropoietic response in swimmers.","date":"2006","source":"Medicine and science in sports and exercise","url":"https://pubmed.ncbi.nlm.nih.gov/16888453","citation_count":24,"is_preprint":false},{"pmid":"32473641","id":"PMC_32473641","title":"Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cell apoptosis by reducing HIF-1α/mTOR-mediated autophagy.","date":"2020","source":"World journal of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32473641","citation_count":24,"is_preprint":false},{"pmid":"23873797","id":"PMC_23873797","title":"HIF-1α in heart: protective mechanisms.","date":"2013","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23873797","citation_count":23,"is_preprint":false},{"pmid":"25778315","id":"PMC_25778315","title":"Expression and significance of FOXP1, HIF-1a and VEGF in renal clear cell carcinoma.","date":"2015","source":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25778315","citation_count":23,"is_preprint":false},{"pmid":"29447016","id":"PMC_29447016","title":"TGF-b1 or hypoxia enhance glucose metabolism and lactate production via HIF1A signaling in tendon cells.","date":"2018","source":"Connective tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/29447016","citation_count":22,"is_preprint":false},{"pmid":"38786726","id":"PMC_38786726","title":"Metabolic Roles of HIF1, c-Myc, and p53 in Glioma Cells.","date":"2024","source":"Metabolites","url":"https://pubmed.ncbi.nlm.nih.gov/38786726","citation_count":21,"is_preprint":false},{"pmid":"34680921","id":"PMC_34680921","title":"Integrative Map of HIF1A Regulatory Elements and Variations.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34680921","citation_count":21,"is_preprint":false},{"pmid":"38476024","id":"PMC_38476024","title":"CARM1 drives triple-negative breast cancer progression by coordinating with HIF1A.","date":"2024","source":"Protein & cell","url":"https://pubmed.ncbi.nlm.nih.gov/38476024","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45458,"output_tokens":6075,"usd":0.11375,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14990,"output_tokens":4848,"usd":0.098075,"stage2_stop_reason":"end_turn"},"total_usd":0.211825,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"HIF-1α is hydroxylated at proline residues 402 and/or 564 by PHD2 (prolyl hydroxylase domain protein 2), promoting binding of the von Hippel-Lindau protein (VHL), leading to ubiquitination and proteasomal degradation. HIF-1α is also hydroxylated at asparagine residue 803 by FIH-1 (factor inhibiting HIF-1), blocking binding of the p300/CBP coactivator. Both hydroxylation reactions utilize O2 and alpha-ketoglutarate as substrates.\",\n      \"method\": \"Biochemical pathway dissection; enzymatic assays; mutagenesis studies synthesized in pathway review\",\n      \"journal\": \"Science's STKE\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple independent labs, reconstituted enzymatic reactions, mutagenesis; widely replicated foundational mechanism\",\n      \"pmids\": [\"17925579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RACK1 competes with HSP90 for binding to the PAS-A domain of HIF-1α and promotes O2/PHD/VHL-independent, proteasome-dependent degradation of HIF-1α by binding Elongin-C and recruiting the Elongin-B/C E3 ubiquitin ligase complex to HIF-1α.\",\n      \"method\": \"Co-immunoprecipitation, domain-mapping pulldown, ubiquitination assay, proteasome inhibitor experiments\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, domain mapping, functional ubiquitination assay in single focused study with multiple orthogonal methods\",\n      \"pmids\": [\"17361105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Jab1 (Jun activation domain-binding protein 1, fifth subunit of COP9 signalosome) directly interacts with HIF-1α, increases HIF-1α protein stability, enhances HIF-1 transcriptional activity under hypoxia (increasing VEGF expression), and interferes with the binding of p53 to HIF-1α in a Jab1-dependent manner.\",\n      \"method\": \"Yeast two-hybrid screening, GST pull-down assay, co-immunoprecipitation in HEK 293 cells, reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, GST pulldown, functional reporter assay; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"11707426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HIF-1α represses expression of MSH2 and MSH6 (the MutSα mismatch repair complex) by displacing the transcriptional activator Myc from Sp1 binding sites at MutSα gene promoters; Sp1 serves as a molecular switch recruiting HIF-1α to the promoter under hypoxia. This is p53-dependent and causes nucleotide-level genetic instability.\",\n      \"method\": \"Reporter assays, ChIP, siRNA knockdown, gel-shift assays, genetic analysis of human colon cancer specimens\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, reporter assay, functional epistasis (p53-dependence), multiple orthogonal methods, replicated in cell lines and patient specimens\",\n      \"pmids\": [\"15780936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HIF-1α transcriptionally upregulates p53 (both WT and MT) by binding to five response elements in the p53 promoter under hypoxia. The resulting hypoxia-induced p53 protein (transcriptionally inactive) acts as a chaperone, binding HIF-1α and stabilizing its association with downstream DNA response elements (HREs), thereby increasing HIF-1α-regulated gene synthesis.\",\n      \"method\": \"ChIP, luciferase reporter assay, co-immunoprecipitation, protein-DNA binding assays, siRNA knockdown\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, reporter assay, Co-IP, multiple orthogonal methods; single lab\",\n      \"pmids\": [\"31538203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TNFα induces HIF-1α protein accumulation (without affecting HIF-1α mRNA) in an IKKβ-dependent manner. IKKβ overexpression increases HIF-1α protein, and IKKβ inhibition or knockout reduces TNFα-induced HIF-1α and VEGF expression.\",\n      \"method\": \"Western blot, stable transfection, siRNA knockdown, pharmacological inhibition (Bay 11-7082), MEF IKKβ knockout cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO + pharmacological inhibition + overexpression, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"19766100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The histone demethylase KDM4A controls HIF-1α levels by removing the repressive H3K9me3 mark at the HIF1A locus; KDM4A depletion or inactivation causes H3K9me3 accumulation at the HIF1A locus, decreasing HIF-1α mRNA and protein, and reduces hypoxia-driven invasion, migration, and oxygen consumption.\",\n      \"method\": \"KDM4A siRNA knockdown, ChIP for H3K9me3 at HIF1A locus, RT-qPCR, invasion/migration assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, KD with defined phenotype, mRNA/protein readouts; single lab\",\n      \"pmids\": [\"28894274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Intermittent hypoxia (minutes) increases HIF-1α protein through a distinct pathway from chronic hypoxia: KDM4A, KDM4B, and KDM4C histone demethylases are activated by intermittent hypoxia, removing H3K9me3 at the HIF1A locus and increasing HIF1A mRNA. Chronic hypoxia conversely decreases KDM4A/B/C activity, leading to H3K9me3 hypertrimethylation at the HIF1A locus.\",\n      \"method\": \"H3K9me3 ChIP at HIF1A locus, RT-qPCR, KDM4A/B/C inhibition and depletion, protein activity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with locus-specific readout, multiple KDM knockdowns, single lab with multiple methods\",\n      \"pmids\": [\"36174675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PADI4 directly interacts with HIF-1α and citrullinates it at arginine R698. This citrullination blocks VHL binding to HIF-1α, thereby antagonizing HIF-1α ubiquitination and proteasomal degradation, stabilizing HIF-1α.\",\n      \"method\": \"Co-immunoprecipitation, in vitro citrullination assay, site-directed mutagenesis (R698), VHL binding assay, ubiquitination assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic reconstitution with mutagenesis, Co-IP, ubiquitination assay; single lab but multiple orthogonal Tier 1 methods\",\n      \"pmids\": [\"39227578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP51 forms a complex with VHL E3 ligase components (USP51/VHL/CUL2/ELOB/ELOC/RBX1) and directly deubiquitinates HIF-1α, stabilizing it and activating hypoxia-induced gene transcription. Conversely, HIF-1α transcriptionally upregulates USP51, forming a positive feedback loop. SUMOylation of ELOC at K32 inhibits USP51 binding; SENP1-mediated deSUMOylation of ELOC promotes USP51-ELOC interaction and HIF-1α deubiquitination.\",\n      \"method\": \"Co-immunoprecipitation, in vitro deubiquitination assay, ChIP, reporter assay, site-directed mutagenesis (ELOC K32), SUMO assay\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro deubiquitination reconstitution, Co-IP of complex, mutagenesis, ChIP; single lab with multiple Tier 1–2 methods\",\n      \"pmids\": [\"37816999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"BAP1 (BRCA1-associated protein 1) binds HIF-1α during hypoxia, deubiquitylates it, and stabilizes it. BAP1 interacts with the N-terminal region of HIF-1α (where HIF-1α binds DNA and dimerizes with HIF-1β). Mutations of BAP1 residues I675, F678, I679, and L691 abolish interaction with HIF-1α. Loss of BAP1 reduces nuclear HIF-1α levels in hypoxia.\",\n      \"method\": \"Co-immunoprecipitation, computational modeling, BAP1 siRNA knockdown, mutagenesis of BAP1 interaction domain, patient mesothelioma biopsy IHC\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — Co-IP with domain mutagenesis, functional deubiquitylation, siRNA KD in primary cells, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"36656861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PER2 (period circadian clock 2) interacts with HIF-1α and functions as an effector molecule facilitating recruitment of HIF-1α to hypoxia response elements (HREs), including the VEGF promoter HRE. PER2-mediated HIF-1 activation requires HIF-1α N803 to be unhydroxylated (by hypoxia, N803A mutation, or FIH inhibitor deferoxamine), though PER2-HIF-1α interaction itself is independent of N803 hydroxylation status.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, luciferase HRE reporter assay, point mutation (N803A), pharmacological FIH inhibition (deferoxamine), PER2 overexpression\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, ChIP, reporter assay, mutagenesis; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"28963769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HIF1A and NFAT5 coordinate high-salt (Na+)-boosted antibacterial defense in macrophages: HIF1A-dependent increased autophagy and NFAT5-dependent targeting of intracellular E. coli to acidic autolysosomal compartments are both required. The antibacterial activity was not dependent on NOS2 or phagocyte oxidase.\",\n      \"method\": \"Conditional KO (LysM-Cre Hif1a and NFAT5 deletion), bacterial colony forming unit assays, autophagic flux assays, lysosomal acidification assays\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type specific genetic KO with defined antibacterial phenotype, multiple readouts; single lab\",\n      \"pmids\": [\"30982460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"HIF-1α activates non-canonical target genes in oligodendrocyte progenitor cells (OPCs) through physical interaction with the OPC-specific transcription factor OLIG2; non-canonical targets Ascl2 and Dlx3 suppress Sox10 and block oligodendrocyte differentiation. MEK/ERK inhibition restores Sox10 expression and oligodendrocyte generation without affecting canonical HIF-1α activity.\",\n      \"method\": \"Chronic HIF-1α accumulation model in PSC-derived OPCs, ChIP-seq, gene expression profiling, chemical MEK/ERK inhibitor screen, human oligocortical spheroid model\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq, genetic loss-of-function with defined phenotype, chemical rescue; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"33091368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cardiac fibroblast-specific deletion of Hif-1a leads to increased mitochondrial ROS after myocardial infarction, resulting in ~50% increased cardiac fibroblast proliferation and excessive scarring. The mitochondrial-targeted antioxidant MitoTEMPO rescues the mutant phenotype, indicating HIF-1α acts as a brake against excessive post-ischemic fibroblast activation through regulation of mitochondrial ROS.\",\n      \"method\": \"CF-specific Cre-lox Hif-1a deletion, scRNA-seq, 3D engineered cardiac microtissues, MitoParaquat treatment, MitoTEMPO rescue, ROS measurement\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific genetic KO, scRNA-seq, rescue with targeted antioxidant, 3D tissue model; multiple orthogonal methods with mechanistic rescue\",\n      \"pmids\": [\"34762860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HIF-1α directly binds to functional hypoxia response elements (HREs) in the S100A8 and S100A9 promoters (confirmed by ChIP) and activates their transcription in prostate cancer cells, as demonstrated by promoter luciferase reporter constructs.\",\n      \"method\": \"ChIP, luciferase promoter reporter assay, HIF-1α overexpression, siRNA knockdown, hypoxia treatment\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP + reporter assay + KD/OE; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"22505354\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HIF1A binds to HRE elements in the WASF3 (WAVE3) gene promoter under hypoxic conditions (confirmed by ChIP), activating WASF3 transcription and promoting cell motility and invasion; WASF3 knockdown abolishes the hypoxic invasion response.\",\n      \"method\": \"ChIP, luciferase reporter assay, WASF3 siRNA knockdown, scratch wound motility assay, hypoxia treatment\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, reporter assay, functional KD; single lab with multiple methods\",\n      \"pmids\": [\"22581642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Intracellular calcium elevation (via ionomycin) and calmodulin activity are required for hypoxia-induced HIF-1 transcriptional activation, acting upstream of the ERK pathway. ERK pathway inhibition (PD98059) blocks HIF-1 activation by both hypoxia and ionomycin without affecting HIF-1α protein level or DNA binding, indicating calcium/calmodulin→ERK regulates HIF-1 transcriptional activity post-DNA binding.\",\n      \"method\": \"Pharmacological inhibition (ionomycin, BAPTA, calmodulin dominant-negative mutant, PD98059, KN-93), HIF-1 reporter assay, electrophoretic mobility shift assay (EMSA)\",\n      \"journal\": \"Annals of the New York Academy of Sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pharmacological inhibitors only, single lab, no genetic validation\",\n      \"pmids\": [\"12485909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"STAT1 functions as a transcriptional suppressor of HIF1A: ATG7 deletion in endothelial cells upregulates STAT1 (via an autophagy-independent mechanism involving ZNF148/ZFP148 nuclear translocation), which binds the HIF1A promoter and suppresses HIF1A expression, impairing angiogenesis. HIF1A overexpression rescues the ATG7-deficiency angiogenesis defect.\",\n      \"method\": \"EC-specific Atg7 KO mouse, ChIP (STAT1 on HIF1A promoter), HIF1A overexpression rescue, ZNF148 nuclear fractionation, fludarabine STAT1 inhibition\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, genetic KO with defined phenotype, rescue experiment; single lab\",\n      \"pmids\": [\"36300763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CARM1 is physically associated with and directly interacts with HIF1A; CARM1 is recruited by HIF1A and occupies promoters of CDK4, Cyclin D1, β-Catenin, HIF1A, MALAT1, and SIX1, modulating proliferation and invasion in triple-negative breast cancer.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-seq (genome-wide CARM1 occupancy), siRNA knockdown, overexpression functional assays\",\n      \"journal\": \"Protein & cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP-seq with functional KD; single lab\",\n      \"pmids\": [\"38476024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HIF-1α loss from skeletal muscle (conditional KO) increases oxidative capacity and constitutively activates AMP-activated protein kinase (AMPK), decreases expression of pyruvate dehydrogenase kinase I (a HIF-1α target), and increases capillary-to-fiber ratio, demonstrating HIF-1α normally suppresses mitochondrial biogenesis and oxidative metabolism in skeletal muscle.\",\n      \"method\": \"Skeletal muscle-specific Hif-1α KO mice, respiratory exchange ratio, capillary density quantification, oxidative enzyme activity, AMPK activation assay\",\n      \"journal\": \"Advances in experimental medicine and biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific genetic KO with multiple defined phenotypic readouts; single lab\",\n      \"pmids\": [\"18269201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In bovine granulosa cells, HIF1 transcriptionally regulates steroidogenesis genes (STAR, HSD3B, CYP19A1) and proliferation genes (CCND2, PCNA); CYP19A1 (aromatase) is a direct downstream target of HIF1, as demonstrated by ChIP showing HIF1A binding to its promoter.\",\n      \"method\": \"Echinomycin inhibition, siRNA knockdown, ChIP, radioimmunoassay (estradiol), RT-qPCR\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP + functional KD with gene expression and hormone assay; single lab\",\n      \"pmids\": [\"32127571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HIF-1 activates transcription of pyruvate dehydrogenase kinase 1 (PDK1), which shunts pyruvate away from mitochondria, and BNIP3, which triggers selective mitochondrial autophagy, thereby coordinating a shift from oxidative phosphorylation to glycolysis under hypoxia.\",\n      \"method\": \"Transcriptional target gene analysis, reporter assays, genetic deletion models (synthesized in review of primary experiments)\",\n      \"journal\": \"Current opinion in genetics & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Strong — PDK1 and BNIP3 as HIF-1 transcriptional targets established by multiple independent labs with reporter and ChIP data\",\n      \"pmids\": [\"19942427\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HIF-1α is an oxygen-sensitive bHLH-PAS transcription factor that, under hypoxia, escapes PHD2-mediated prolyl hydroxylation (at P402/P564) and VHL-dependent ubiquitin-proteasomal degradation, dimerizes with HIF-1β, recruits coactivators p300/CBP (whose binding is also regulated by FIH-1-mediated N803 hydroxylation), and drives transcription of hundreds of target genes including VEGF, glycolytic enzymes, PDK1, and BNIP3; its stability is additionally controlled by O2-independent mechanisms including RACK1-mediated (competing with HSP90) and BAP1/USP51 deubiquitylase-mediated pathways, post-translational modifications such as PADI4-mediated citrullination at R698 that blocks VHL binding, epigenetic regulation of the HIF1A locus via KDM4A/H3K9me3, and interactions with partners including Jab1, PER2, CARM1, and p53 that modulate its transcriptional output in a context-dependent manner.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"HIF-1α is the master oxygen-sensitive bHLH-PAS transcription factor that reprograms cellular physiology in response to hypoxia [#0, #22]. Under normoxia its stability and activity are controlled by O2-dependent dioxygenases: PHD2 hydroxylates P402/P564 to license VHL-mediated ubiquitination and proteasomal degradation, while FIH-1 hydroxylates N803 to block recruitment of the p300/CBP coactivator, both using O2 and α-ketoglutarate as cosubstrates [#0]. Beyond this canonical axis, HIF-1α abundance is set by O2-independent inputs that converge on the same ubiquitin machinery: RACK1 competes with HSP90 for the PAS-A domain and recruits the Elongin-B/C ligase to drive degradation [#1], whereas the deubiquitylases USP51 (acting within a VHL/CUL2/ELOB/ELOC complex regulated by SENP1-dependent deSUMOylation of ELOC) and BAP1 remove ubiquitin to stabilize HIF-1α [#9, #10]; PADI4-mediated citrullination at R698 stabilizes the protein by blocking VHL binding [#8], and inflammatory signaling through IKKβ raises HIF-1α protein without changing its mRNA [#5]. HIF1A expression is additionally gated epigenetically, with KDM4-family histone demethylases removing repressive H3K9me3 at the locus—an axis that distinguishes intermittent from chronic hypoxia—and STAT1 acting as a transcriptional repressor of the promoter [#6, #7, #18]. Once stabilized and dimerized, HIF-1α binds hypoxia response elements to activate a metabolic and angiogenic program, inducing PDK1 and BNIP3 to shift cells from oxidative phosphorylation to glycolysis [#22] and driving targets including VEGF, S100A8/A9, WASF3, and CYP19A1 [#2, #15, #16, #21]. Its transcriptional output is shaped combinatorially by partner factors—PER2 facilitates HRE recruitment, p53 acts as a chaperone stabilizing HIF-1α at HREs, CARM1 co-occupies target promoters, Sp1 switches HIF-1α onto the MutSα mismatch-repair genes to repress them, and OLIG2 redirects HIF-1α to non-canonical targets in oligodendrocyte progenitors [#11, #4, #19, #3, #13]. Physiologically, HIF-1α enforces tissue-specific outcomes, suppressing mitochondrial biogenesis in skeletal muscle [#20], limiting post-ischemic cardiac fibroblast proliferation by controlling mitochondrial ROS [#14], and supporting macrophage autophagy-dependent antibacterial defense [#12].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying Jab1 as a direct HIF-1α partner showed that protein-protein interactions, not just oxygen chemistry, govern HIF-1α stability and activity.\",\n      \"evidence\": \"Yeast two-hybrid, GST pulldown, Co-IP and reporter assays in HEK293 cells\",\n      \"pmids\": [\"11707426\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of the Jab1-HIF-1α interface not defined\", \"Whether Jab1 acts via the COP9 signalosome in this context untested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that HIF-1α displaces Myc at Sp1 sites to repress MutSα genes established HIF-1α as a context-dependent transcriptional repressor causing genetic instability, not only an activator.\",\n      \"evidence\": \"ChIP, reporter and gel-shift assays, siRNA, p53-dependence epistasis in colon cancer cells and patient specimens\",\n      \"pmids\": [\"15780936\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality of the Sp1 switch to other promoters unknown\", \"Direct vs indirect role of p53 in repression not fully resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Dissection of PHD2/VHL and FIH-1 hydroxylation reactions defined the dual O2-dependent control of HIF-1α stability and coactivator recruitment, the foundational oxygen-sensing mechanism.\",\n      \"evidence\": \"Enzymatic assays and mutagenesis synthesized in pathway review\",\n      \"pmids\": [\"17925579\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative O2 thresholds for each hydroxylase in vivo not specified\", \"Crosstalk between the two hydroxylation events under graded hypoxia\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showing RACK1 competes with HSP90 and recruits Elongin-B/C established an O2/PHD/VHL-independent route to HIF-1α degradation, expanding stability control beyond the hydroxylase axis.\",\n      \"evidence\": \"Reciprocal Co-IP, domain mapping, ubiquitination and proteasome-inhibitor assays\",\n      \"pmids\": [\"17361105\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological signals that tip the HSP90/RACK1 balance unclear\", \"Tissue contexts where this pathway dominates not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linking TNFα/IKKβ to HIF-1α protein accumulation connected inflammatory signaling to HIF-1α independent of transcription, broadening its regulatory inputs.\",\n      \"evidence\": \"Western blot, overexpression, siRNA, pharmacological inhibition and IKKβ-KO MEFs\",\n      \"pmids\": [\"19766100\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular step by which IKKβ raises HIF-1α protein not identified\", \"Whether degradation or translation is targeted unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Tissue-specific knockouts revealed HIF-1α as a physiological brake on oxidative metabolism in skeletal muscle and a coordinator of the glycolytic switch via PDK1 and BNIP3.\",\n      \"evidence\": \"Skeletal-muscle Hif1a KO mice with metabolic phenotyping; transcriptional target analysis of PDK1/BNIP3\",\n      \"pmids\": [\"18269201\", \"19942427\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of individual targets to the metabolic phenotype unclear\", \"Cross-tissue generality of the metabolic brake untested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"ChIP-validated direct targets S100A8/A9 and WASF3 connected HIF-1α transcriptional activity to invasion and motility programs in cancer cells.\",\n      \"evidence\": \"ChIP, reporter assays, siRNA knockdown, motility assays under hypoxia\",\n      \"pmids\": [\"22505354\", \"22581642\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Contribution relative to other invasion targets not quantified\", \"In vivo metastasis dependence not established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defining KDM4A-mediated H3K9me3 removal at the HIF1A locus established epigenetic control of HIF1A transcription as a distinct regulatory layer.\",\n      \"evidence\": \"KDM4A siRNA, H3K9me3 ChIP at HIF1A, RT-qPCR, invasion/migration assays\",\n      \"pmids\": [\"28894274\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Upstream signals controlling KDM4A activity at this locus unknown\", \"Single-lab observation\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identifying PER2 as an effector that recruits HIF-1α to HREs tied circadian machinery to hypoxic transcription and linked it mechanistically to N803 hydroxylation status.\",\n      \"evidence\": \"Reciprocal Co-IP, ChIP, HRE reporter, N803A mutation and FIH inhibition\",\n      \"pmids\": [\"28963769\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PER2 acts on canonical or specific subsets of HREs unclear\", \"Circadian timing of the effect not directly tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"p53 was shown to act both as a HIF-1α transcriptional target and as a chaperone stabilizing HIF-1α at HREs, revealing reciprocal HIF-1α/p53 regulation.\",\n      \"evidence\": \"ChIP, luciferase reporter, Co-IP, protein-DNA binding, siRNA\",\n      \"pmids\": [\"31538203\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which transcriptionally inactive p53 stabilizes DNA binding unclear\", \"In vivo relevance of the feed-forward loop untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Genetic dissection placed HIF1A within macrophage salt-boosted antibacterial defense and identified STAT1 as a transcriptional repressor of HIF1A controlling angiogenesis.\",\n      \"evidence\": \"Conditional/EC-specific KO mice, ChIP, autophagy/lysosomal assays, HIF1A overexpression rescue\",\n      \"pmids\": [\"30982460\", \"36300763\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct HIF-1α target genes in the antibacterial program not all defined\", \"STAT1 repression generality across tissues unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Cell-type-specific studies established HIF-1α as a protective brake on cardiac fibroblast proliferation via mitochondrial ROS control and as a driver of non-canonical, OLIG2-dependent transcription blocking oligodendrocyte differentiation.\",\n      \"evidence\": \"Conditional Hif1a KO, scRNA-seq, ChIP-seq, MitoTEMPO rescue, MEK/ERK inhibitor rescue, spheroid models\",\n      \"pmids\": [\"34762860\", \"33091368\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How HIF-1α selects non-canonical vs canonical targets mechanistically unresolved\", \"ROS target genes mediating the fibroblast brake not enumerated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovery of USP51 and BAP1 as HIF-1α deubiquitylases established active deubiquitylation, including a SENP1/SUMO-regulated USP51 feedback loop, as a positive arm of HIF-1α stability control.\",\n      \"evidence\": \"Co-IP of complexes, in vitro deubiquitination, ChIP, ELOC K32 and BAP1 interaction-domain mutagenesis, patient IHC\",\n      \"pmids\": [\"37816999\", \"36656861\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of USP51 vs BAP1 across cell types unclear\", \"Conditions activating each DUB physiologically not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of PADI4-mediated R698 citrullination as a VHL-blocking modification, and CARM1 as a recruited co-regulator on shared promoters, extended the post-translational and cofactor repertoire controlling HIF-1α.\",\n      \"evidence\": \"In vitro citrullination, Co-IP, R698 mutagenesis, VHL/ubiquitination assays; CARM1 Co-IP and ChIP-seq with functional knockdown\",\n      \"pmids\": [\"39227578\", \"38476024\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals controlling PADI4 recruitment to HIF-1α unknown\", \"Whether CARM1 methylates HIF-1α directly not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many parallel stability inputs (hydroxylation, RACK1, DUBs, citrullination, IKKβ) and combinatorial cofactors are integrated to set context-specific HIF-1α target selection remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified quantitative model linking competing stability pathways\", \"Determinants of canonical vs non-canonical target choice undefined\", \"Structural basis of most HIF-1α cofactor interfaces unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 4, 15, 16, 21, 22]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [4, 15, 16]},\n      {\"term_id\": \"GO:0003700\", \"supporting_discovery_ids\": [22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [0, 22]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 15, 16, 22]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [20, 22]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 8, 9, 10]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"VHL\", \"PHD2\", \"FIH1\", \"RACK1\", \"PADI4\", \"USP51\", \"BAP1\", \"PER2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}